Majority of the primary glioblastoma mutations include those of EGFR (epidermal growth factor receptor) amplifications (40%–60%), p53 (tumor protein P53) mutations (30%), PTEN (phosphatase and TENsin homolog) mutations (25%), and the loss of entire chromosome 10 (70%). Here, EGFR is linked to glioblastoma.